Turkish doctors estimate the effectiveness of the Chinese CoronaVac vaccine at 83.5%, Report informs, citing Turkey's Hacettepe University.
The third phase of vaccine trials began in Turkey in October. The study results also showed that the drug reduces the risk of hospitalization by 100%.
Meanwhile, Sinovac Biotech, the manufacturer, estimates the drug’s effectiveness at 62.3% after two doses. The interval between the doses should be 28 days.
Turkey began mass vaccination of the population against coronavirus on Jan. 14.